Nanobiotix S.A. (NBTX) stock
NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$27.45−1.09 (-3.82%)
Close on Nov 17, 2026Market cap $1.33BP/E –Yield –
Nanobiotix operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was -33.2%, against -74.0% the year before. The highest annual figure on record is -33.2% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -33.2% | +40.8 |
| FY2023 | Dec 31, 2023 | -74.0% | +903.9 |
| FY2022 | Dec 31, 2022 | -977.8% | +1008.5 |
| FY2021 | Dec 31, 2021 | -1986.4% | −536.2 |
| FY2020 | Dec 31, 2020 | -1450.2% | +390.8 |
| FY2019 | Dec 31, 2019 | -1841.0% | −976.7 |
| FY2018 | Dec 31, 2018 | -864.2% | – |
See a number that looks wrong?